Natasha J. Caplen

Last updated
Natasha J. Caplen
Natasha J. Caplen.jpg
Alma mater King's College Hospital Medical School (PhD)
Scientific career
FieldsGenetics, cancer biology
Institutions National Human Genome Research Institute
National Cancer Institute
Thesis A Study of the Genetics of Insulin-Dependent Diabetes Mellitus and its Microvascular Complications  (1991)

Natasha Jane Caplen is a British-American geneticist who discovered RNA interference (RNAi) in mammalian cells. She is a senior investigator and head of the functional genetics section at the National Cancer Institute.

Contents

Education

Caplen completed a Ph.D. from the King's College Hospital Medical School where she studied the genetics of type I diabetes and its complications. [1] Her dissertation in 1991 was titled, A Study of the Genetics of Insulin-Dependent Diabetes Mellitus and its Microvascular Complications. [2] Caplen's postdoctoral training began at St Mary's Hospital Medical School where she focused on the development of gene therapy approaches for cystic fibrosis (CF) during which she was involved in some of the first pre-clinical and clinical studies of cationic lipid mediated gene therapy for CF. [1] [3]

Career and research

In 1996, Caplen came to the National Human Genome Research Institute (NHGRI) at NIH as a visiting fellow, where she initially conducted studies investigating hybrid viral vector systems. It was while at NHGRI that Caplen developed a research interest in the newly identified gene silencing mechanism, RNA interference (RNAi) leading to her studies that establish the presence of RNAi in mammalian cells. Caplen joined the Center for Cancer Research (CCR) at the National Cancer Institute (NC) in 2004 as a Senior Scientist, where she pioneered approaches for exploiting RNAi to investigate cancer biology and treatment and helped establish a trans-NIH facility for genome-wide RNAi screening. Caplen was appointed a tenure-track investigator in CCR's Genetics Branch in January 2016. She is head of the functional genetics section. Her research focuses on using functional genetic methods to interrogate specific aspects of the genetic, transcriptional, and signaling alterations observed in cancers driven by fusion oncogenes. [1]

Related Research Articles

Gene knockdown is an experimental technique by which the expression of one or more of an organism's genes is reduced. The reduction can occur either through genetic modification or by treatment with a reagent such as a short DNA or RNA oligonucleotide that has a sequence complementary to either gene or an mRNA transcript.

<span class="mw-page-title-main">Functional genomics</span> Field of molecular biology

Functional genomics is a field of molecular biology that attempts to describe gene functions and interactions. Functional genomics make use of the vast data generated by genomic and transcriptomic projects. Functional genomics focuses on the dynamic aspects such as gene transcription, translation, regulation of gene expression and protein–protein interactions, as opposed to the static aspects of the genomic information such as DNA sequence or structures. A key characteristic of functional genomics studies is their genome-wide approach to these questions, generally involving high-throughput methods rather than a more traditional "candidate-gene" approach.

<span class="mw-page-title-main">National Human Genome Research Institute</span> Institute of the National Institutes of Health, located in Bethesda, Maryland, US

The National Human Genome Research Institute (NHGRI) is an institute of the National Institutes of Health, located in Bethesda, Maryland.

Mitochondrially encoded tRNA leucine 1 (UUA/G) also known as MT-TL1 is a transfer RNA which in humans is encoded by the mitochondrial MT-TL1 gene.

Mitochondrially encoded tRNA glutamic acid also known as MT-TE is a transfer RNA which in humans is encoded by the mitochondrial MT-TE gene. MT-TE is a small 69 nucleotide RNA that transfers the amino acid glutamic acid to a growing polypeptide chain at the ribosome site of protein synthesis during translation.

Complications of diabetes are secondary diseases that are a result of elevated blood glucose levels that occur in diabetic patients. These complications can be divided into two types: acute and chronic. Acute complications are complications that develop rapidly and can be exemplified as diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar state (HHS), lactic acidosis (LA), and hypoglycemia. Chronic complications develop over time and are generally classified in two categories: microvascular and macrovascular. Microvascular complications include neuropathy, nephropathy, and retinopathy; while cardiovascular disease, stroke, and peripheral vascular disease are included in the macrovascular complications.

Most cases of type 2 diabetes involved many genes contributing small amount to the overall condition. As of 2011 more than 36 genes have been found that contribute to the risk of type 2 diabetes. All of these genes together still only account for 10% of the total genetic component of the disease.

John B. Hogenesch is an American chronobiologist and Professor of Pediatrics at the Cincinnati Children's Hospital Medical Center. The primary focus of his work has been studying the network of mammalian clock genes from the genomic and computational perspective to further the understanding of circadian behavior. He is currently the Deputy Director of the Center for Chronobiology, an Ohio Eminent Scholar, and Professor of Pediatrics in the Divisions of Perinatal Biology and Immunobiology at the Cincinnati Children's Hospital Medical Center.

<span class="mw-page-title-main">Elaine Ostrander</span> American geneticist

Elaine Ann Ostrander is an American geneticist at the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) in Bethesda, Maryland. She holds a number of professional academic appointments, currently serving as Distinguished and Senior Investigator and head of the NHGRI Section of Comparative Genomics; and Chief of the Cancer Genetics and Comparative Genomics Branch. She is known for her research on prostate cancer susceptibility in humans and for conducting genetic investigations with the Canis familiaris —the domestic dog— model, which she has used to study disease susceptibility and frequency and other aspects of natural variation across mammals. In 2007, her laboratory showed that much of the variation in body size of domestic dogs is due to sequence changes in a single gene encoding a growth-promoting protein.

<span class="mw-page-title-main">Katherine McJunkin</span> American biologist

Katherine McJunkin is an American biologist. She is the Stadtman Investigator in the Section On Regulatory RNAs, Laboratory of Cellular and Developmental Biology at the National Institute of Diabetes and Digestive and Kidney Diseases.

<span class="mw-page-title-main">Joan Bailey-Wilson</span> American statistical geneticist

Joan Ellen Bailey-Wilson is an American statistical geneticist. She is a senior investigator and co-chief of the Computational and Statistical Genomic Branch of the National Human Genome Research Institute.

<span class="mw-page-title-main">H. Efsun Arda</span> Turkish developmental and systems biologist

Hatice Efsun Arda is a Turkish developmental and systems biologist researching cell lineages that give rise to human pancreas using single cell sequencing. She is a Stadtman principal investigator and head of the developmental genomics group at the National Cancer Institute.

<span class="mw-page-title-main">Stavroula Mili</span> Greek molecular biologist

Stavroula "Voula" Mili is a Greek molecular biologist researching the regulation, functional consequences, and disease associations of localized RNAs. She is a NIH Stadtman Investigator at the National Cancer Institute.

<span class="mw-page-title-main">Sheue-yann Cheng</span> American molecular geneticist

Sheue-yann Cheng is an American molecular geneticist who pioneered the development of mouse models to understand the molecular basis of diseases due to mutations of thyroid hormone receptors. Cheng is a senior investigator at the National Cancer Institute and chief of the gene regulation section.

<span class="mw-page-title-main">Wei-Shau Hu</span> American geneticist

Wei-Shau Hu is an American geneticist specialized in HIV research, retroviral recombination, RNA packaging, and virus assembly. She is a senior investigator at the National Cancer Institute and head of the viral recombination section. She was an associate professor at West Virginia University.

<span class="mw-page-title-main">Cuilin Zhang</span> Chinese epidemiologist and physician-scientist

Cuilin Zhang is a Chinese-American epidemiologist and physician-scientist researching the roles of genetic and environmental factors in the pathogenesis of gestational diabetes, type 2 diabetes, and obesity and health consequences of these complications. Zhang is a senior investigator and acting chief of the epidemiology branch at the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

<span class="mw-page-title-main">Xiaohong Rose Yang</span> Biomedical scientist

Xiaohong Rose Yang is an American biomedical scientist researching the genetics of dysplastic nevus syndrome and chordoma, and etiologic heterogeneity of breast cancer. She is a senior investigator at the National Cancer Institute. Yang leads breast cancer studies in mainland China, Hong Kong, and Malaysia.

<span class="mw-page-title-main">Tracey Rouault</span> American rheumatologist and physician-scientist

Tracey Ann Rouault is an American rheumatologist and physician-scientist who researches mammalian iron-sulfur proteins. Rouault is a senior investigator at the Eunice Kennedy Shriver National Institute of Child Health and Human Development and she heads the section on human iron metabolism.

Ludmila Prokunina-Olsson is a molecular medical geneticist who conducts genetic and functional analyses downstream of genome-wide association studies (GWAS) for various human traits, including cancer, immune and infectious diseases. She is chief of the Laboratory of Translational Genomics (LTG) at the National Cancer Institute.

References

  1. 1 2 3 "Natasha J. Caplen, Ph.D." Center for Cancer Research. 2014-08-12. Retrieved 2020-07-23.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  2. Caplen, Natasha Jane (1991). A Study of the Genetics of Insulin-Dependent Diabetes Mellitus and its Microvascular Complications (Ph.D. thesis). University of London. OCLC   1124129775.
  3. "Principal Investigators". NIH Intramural Research Program. Retrieved 2020-07-23.PD-icon.svg This article incorporates text from this source, which is in the public domain .
PD-icon.svg This article incorporates public domain material from websites or documents of the National Institutes of Health.